Prof. Dirk Heckl Director of the institute for Experimental Paediatric Haematology and Oncology
Prof. Dirk Heckl takes on a new position and joins the rest of the leukemia research team in Frankfurt.
Commentary: IRAK1/4 inhibitors in MDS/AML
In this commentary Dr. Uckelmann and Prof. Klusmann point out recent findings that highlight the therapeutic potential of cotargeting IRAK1 and IRAK4.
International Symposium on Stem Cells and Cancer
The lab members made their way to the dkfz in Heidelberg to take part in the 11th International Symposium on Stem Cell and Cancer to present their latest work.
Jan-Henning Klusmann as new member with the German National Academy of Sciences
Prof. Klusmann was awarded with a membership of the Leopoldina, Germany's National Academy of Sciences.
Influenza A (H1N1) virus induced long-term remission in a refractory acute myeloid leukaemia
In our commentary we highlight a special case of refractory AML, which went into complete remission after Influenza A infection.
Preclinical testing of miR-193b-3p mimic in AML
Today the work of our PostDoc Dr. Hasan Issa and colleagues was publishe in Leukemia. It presents the anti-leukemic effects of microRNA-193b-3p and its clincial potential.
Annual Kind-Phillip-Meeting in Wilsede 2023
Last week, the members of the leukemia research group made their way to Wilsede for the annual Kind-Philip-Meeting. A four day meeting packed with great invited lectures and insightfull presentations.
Leukemia Explained: step by step
Leukemia explained: In the latest episode of the KGU Gesundheitsforum Prof. Jan-Henning Klusmann gives a straightforward explanation to the origins of leukemia and our treatment advances, featuring Stephanie as special guest.
Rhein-Main Cancer Retreat 2023
Konstantin presents a talk about his project progress at the 4th Rhein-Main Cancer Retreat. Other representatives of AG Klusmann were Leah, Anna-Lena and Stephanie presenting respective posters.
Increasing Server Capacity
An exiting delivery has arrived at the lab. A new server cabinet and additonal equipment was setup by our bioinformatics team. The new set up will provide extended data storage and increased computational capacities.